GlaxoSmithKline’s, Nucala receives FDA approval to treat severe asthma
by Staff from Outbreak News Today on (#SM0S)
The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines. Asthma is a chronic disease that ["]
